After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Halozyme Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Halozyme Therapeutics Inc is $8.05B. A total of 4.0 million shares were traded on the day, compared to an average of 1.29M shares.
In the most recent transaction, Henderson Jeffrey William sold 5,000 shares of HALO for 58.69 per share on Mar 03 ’25. After the transaction, the Director now owns 33,611 company shares. In a previous transaction on Feb 26 ’25, LaBarre Michael J. sold 10,000 shares at 58.12 per share. HALO shares that SVP, CHIEF TECHNICAL OFFICER owns now total 175,453.
Among the insiders who sold shares, LaBarre Michael J. disposed of 10,000 shares on Feb 25 ’25 at a per-share price of $58.05. This resulted in the SVP, CHIEF TECHNICAL OFFICER holding 185,453 shares of HALO after the transaction. In another insider transaction, LaBarre Michael J. sold 1,697 shares at $58.28 per share on Feb 27 ’25. Company shares held by the SVP, CHIEF TECHNICAL OFFICER now total 173,756.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, HALO has a high of $65.53 and a low of $37.73.
As of this writing, HALO has an earnings estimate of $0.95 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $1.08 per share and a lower estimate of $0.85.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $2.95, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 4.11.
